Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Utility of Prediction Scores for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Treated with Nucleos(t)ide Analogues.

Oncology - 1 Jan 2016

Tawada Akinobu, Chiba Tetsuhiro, Saito Tomoko, Ogasawara Sadahida, Suzuki Eiichiro, Ooka Yoshihiko, Arai Makoto, Kanda Tatsuo, Shinozaki Masami, Goto Nobuaki, Nagashima Kengo, Yokosuka Osamu

Abstract excerpt

OBJECTIVE: The utility of risk scores to predict the development of hepatocellular carcinoma (HCC) in chronic hepatitis B (CHB) patients treated with nucleos(t)ide analogue (NA) remains to be elucidated. METHODS: CU-HCC (The Chinese University of Hong Kong-HCC) and GAG-HCC (Guide with Age, Gender, HBV DNA, Core promoter mutations and Cirrhosis) scores of 225 Japanese patients treated with NAs for at least 2 years...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bilirubin
Share to Carcinoma, Hepatocellular

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Hepatitis B, Chronic

Share to Hepatitis B virus

Share to Liver Cirrhosis

Share to Liver Neoplasms

Share to Serum Albumin

Source

Identifiers

PMID: 26934505
DOI: 10.1159/000444392

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Utility of Prediction Scores for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Treated with Nucleos(t)ide Analogues.PMID 26934505Read ↗

Prediction models of hepatocellular carcinoma development in chronic hepatitis B patients.Semantic proximity Read ↗

Can we use HCC risk scores to individualize surveillance in chronic hepatitis B infection?Semantic proximity Read ↗

Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B.Semantic proximity Read ↗

Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles.Semantic proximity Read ↗

Nomograms predicting benefit after immunotherapy in oral bifidobacteria supplementation ICC patients: a retrospective studySemantic proximity Read ↗

Hepatitis B Virus Combo Mutations Improve the Prediction and Active Prophylaxis of Hepatocellular Carcinoma: A Clinic-Based Cohort Study.Semantic proximity Read ↗

Factors associated with hepatocellular carcinoma occurrence after HCV eradication in patients without cirrhosis or with compensated cirrhosis.Semantic proximity Read ↗

Predicting Hepatitis B Virus (HBV) Surface Antigen Seroclearance in HBV e Antigen-Negative Patients With Chronic Hepatitis B: External Validation of a Scoring System.Semantic proximity Read ↗

Nucleos(t)ide Analogue Treatment for Patients With Hepatitis B Virus (HBV) e Antigen-Positive Chronic HBV Genotype C Infection: A Nationwide, Multicenter, Retrospective Study.Semantic proximity Read ↗

A predictive scoring system for the seroclearance of HBsAg in HBeAg-seronegative chronic hepatitis B patients with genotype B or C infection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.